| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd0226bc5956444f686893e2aea57281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e342349ce44ed43f8474abbf88641263
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89b2e8d6f78822ec0177474bbdc42fe0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ea35390070be41ad935b4ddfaa0f991 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2009-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c7fc58e3b5a9bc6e3c5d15b613f924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ecc6991919f626e7ef3b0f9afbe62c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_254966f28caa152a72b8d8faff72751a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47849645208209ed0cd47a20cf9df52 |
| publicationDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8173614-B2 |
| titleOfInvention |
Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof |
| abstract |
The invention provides novel combination therapies for treating Huntington's disease which comprise a) BDNF or suitable fragments thereof and b) agents capable of causing inhibition of a gene responsible for the neurodegenerative disease. The invention provides nucleic acid sequences, methods, and systems suitable for applications of these combination therapies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542506-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434502-B2 |
| priorityDate |
2007-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |